Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Delipidation of bile samples using Cleanascite™ for comparative proteomic analysisAdequate sample preparation using Cleanascite™ allows proteomic profiling of bile and identification of cancer biomarkers for personalized medicine research
By: Biotech Support Group For detailed protocols of the published article click http://www.sciencedirect.com/ Characteristics of Cleanascite™ Lipid Removal Reagent and Clarification Helps purify antibodies, recombinant proteins, nucleic acids, proteoglycans Ideal for clarifying ascites, serum, cell & tissue culture, bile and organ homogenates Clarifies saliva and fecal components Very low protein binding Does not bind to DNA, RNA, enzymes and proteins Leaves glycoproteins, antibodies, nucleic acids, hemoglobin, proteoglycans, nucleic acids, serum components(such as hormones, nutrients, globulins, clotting factors, transport proteins) alone Extends the life of membrane and chromatographic columns. Enrichment of delipidated tissue samples Ideal for delipidation treatments for downstream processing of large-scale therapeutic proteins, enzymes and monoclonal antibodies. Selectively removes lipids, cell debris, lipoproteins, floating fats, impurities from cohn paste, transgenic milk, egg yolk and biological samples for pretreatment of samples prior to purification. For more information visit: Cleanascite™ Lipid Removal Reagent and Clarification http://www.biotechsupportgroup.com/ About Biotech Support Group LLC Biotech Support Group LLC is a leading provider of genomics and proteomics sample preparation products and enrichment reagent kits as well as integrated biotechnology services for life sciences research, biomarker and drug discovery. Based in New Jersey, it’s principal products include: AlbuVoid™ CONTACT: Dr.Swapan Roy Biotech Support Group 1 Deer Park Drive, Suite M, Monmouth Junction, NJ 08852, USA 732-274-2866 sales@biotechsupportgroup.com References: Bile Farina, Annarita, et al. "Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses." Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics (2013). Boschetti, Egisto, and Pier Giorgio Righetti. Low-Abundance Proteome Discovery: State of the Art and Protocols. Newnes, 2013. Wang W, Ai KX, Yuan Z, Huang XY, Zhang HZ.Different Expression of S100A8 in Malignant and Benign Gallbladder Diseases.Digestive diseases and sciences. 2012. Hauser-Davis RA, Lima AA, Ziolli RL, Campos RC.First-time report of metalloproteinases in fish bile and their potential as bioindicators regarding environmental contamination. Aquatic Toxicology.2012; Farina A, Dumonceau JM, Frossard JL. Proteomic Analysis of Human Bile from Malignant Biliary Stenosis Induced by Pancreatic Cancer Journal of Proteome Research.2009; Guerrier L, Claverol S, Finzi L et al. Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins. Journal of Chromatography.2007; Chen Bo, Zheng Jian-wei, Wang Jian-ming, et al. Establishment and preliminary analysis of a 2-D human biliary map Chinese Journal of Hepatobiliary Surgery.2007 Chen B, Dong JQ, Chen YJ et al Two-dimensional electrophoresis for comparative proteomic analysis of human bile. Hepatobiliary & pancreatic diseases international.2007 Aug;6(4):402- Guerrier L, Claverol S, Finzi L et al Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins.Journal of Chromatography A.2007;1176( Kristiansen TZ, Bunkenborg J, Gronborg M et al A Proteomic Analysis of Human Bile Molecular and Cellular Proteomics.2004; Suggested References Metzger, Jochen, et al. "Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders." Gut 62.1 (2013): 122-130. Kikkawa, Shintaro, et al. "Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry." Shen, Jian, et al. "Comparative Proteomic Profiling of Human Bile Reveals SSP411 as a Novel Biomarker of Cholangiocarcinoma." Farina, Annarita, et al. "A step further in the analysis of human bile proteome."Journal of proteome research 10.4 (2011): 2047-2063. Barbhuiya, Mustafa A., et al. "Comprehensive proteomic analysis of human bile." Proteomics 11.23 (2011): 4443-4453. Shigehara, Kengo, et al. "Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer." PLoS One 6.8 (2011): e23584. Chapman, M. H., et al. "Circulating Cyfra 21-1 Is A Highly Specific Diagnostic And Prognostic Biomarker In Biliary Tract Cancer." (2009): A18-A19. Farina, Annarita, Jean-Marc Dumonceau, and Pierre Lescuyer. "Proteomic analysis of human bile and potential applications for cancer diagnosis." Expert Review of Proteomics 6.3 (2009): 285-301. Bonney, Glenn K., et al. "Circulating markers of biliary malignancy: opportunities in proteomics?." End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|